Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
56,362,930
-
Shares change
-
-4,562,638
-
Total reported value, excl. options
-
$323,576,998
-
Value change
-
-$33,068,798
-
Put/Call ratio
-
224%
-
Number of buys
-
78
-
Number of sells
-
51
-
Price
-
$5.74
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2020
As of 31 Dec 2020 CYMABAY THERAPEUTICS INC - COM (CBAY) had 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,362,930 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, BlackRock Inc., BOXER CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, CITADEL ADVISORS LLC, STATE STREET CORP, Foresite Capital Management IV, LLC, Foresite Capital Management III, LLC, and COMMODORE CAPITAL LP.
This table shows 169 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.